[Skip to Content]
[Skip to Content Landing]
February 18, 2004

Expanded Screening of Newborns for Genetic Disorders

Author Affiliations

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(7):820-821. doi:10.1001/jama.291.7.820-c

To the Editor: Dr Holtzman, in his Editorial1 accompanying our study of expanded newborn screening for biochemical genetic disorders,2 stated that adoption of new screening technology was brought about by pressure from medico-legal proceedings initiated by parents. He did not mention, however, the strong and dedicated advocacy from metabolic and genetic physicians, individually and through organizations such as the Society of Inherited Metabolic disorders, who recognized the potential benefit to patients and their families.

First Page Preview View Large
First page PDF preview
First page PDF preview